[1]. Importance of eosinophilic infiltration of the colonic mucosa in ulcerative colitis patients who are refractory to maintenance therapy: A prospective, single-center study.
Medicine [巻]101 [号]40 [頁]e31017 （2022年） [査読] 有
[DOI] [2]. Effect of disease duration on fecal biomarkers in ulcerative colitis: a prospective cohort study.
BMC gastroenterology [巻]22 [号]1 [頁]420 （2022年） [査読] 有
[DOI] [3]. Modified method of patency judgement using patency capsule prior to capsule endoscopy in clinical practice.
Scientific reports [巻]12 [号]1 [頁]14335 （2022年） [査読] 有
[DOI] [4]. Lymphocyte to monocyte ratio and serum albumin changes predict tacrolimus therapy outcomes in patients with ulcerative colitis.
Scientific reports [巻]12 [号]1 [頁]13572 （2022年） [査読] 有
[DOI] [5]. Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite.
Clinical and translational gastroenterology [巻]13 [号]7 [頁]e00501 （2022年） [査読] 有
[DOI]